Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy
NCT06218602Phase 2Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2024
- Primary completion
- Aug 2028
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in lymphoma, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2024; status: recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT06218602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06218602.